{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:02:01Z","timestamp":1770483721926,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.3109\/14653249.2012.681042","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T09:37:58Z","timestamp":1335519478000},"page":"823-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization."],"prefix":"10.1016","volume":"14","author":[{"given":"Juan-Manuel","family":"Sancho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Morgades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan-Ramon","family":"Grifols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Junc\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Guardia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Vives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Ferr\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monsterrat","family":"Batlle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuensanta","family":"Mill\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evarist","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep-Maria","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3109\/14653249.2012.681042_bib0005","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood.V89.7.2233","article-title":"The biology and clinical uses of blood stem cells","volume":"89","author":"To","year":"1997","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.681042_bib0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1089\/scd.2004.13.598","article-title":"What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?","volume":"13","author":"Jillella","year":"2004","journal-title":"Stem Cells Dev"},{"key":"10.3109\/14653249.2012.681042_bib0015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1080\/10428190903096701","article-title":"Advances in mobilization for the optimization of autologous stem cell transplantation","volume":"50","author":"Vose","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.3109\/14653249.2012.681042_bib0020","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0140-6736(92)90795-5","article-title":"Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy","volume":"339","author":"Sheridan","year":"1992","journal-title":"Lancet"},{"key":"10.3109\/14653249.2012.681042_bib0025","first-page":"277","article-title":"Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants","volume":"9","author":"To","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/scd.1.1994.3.185","article-title":"Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftment","volume":"3","author":"Reiffers","year":"1994","journal-title":"J Hematother"},{"key":"10.3109\/14653249.2012.681042_bib0035","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","article-title":"An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy","volume":"86","author":"Weaver","year":"1995","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.681042_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1537-2995.1998.38298193106.x","article-title":"Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitors cells","volume":"38","author":"Beguin","year":"1998","journal-title":"Transfusion"},{"key":"10.3109\/14653249.2012.681042_bib0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1705763","article-title":"Patients mobilizing large numbers of CD34+ cells (\u2018super mobilizers\u2019) have improved survival in autologous stem cell transplantation for lymphoid malignancies","volume":"40","author":"Bolwell","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0050","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1182\/blood-2011-06-318220","article-title":"How I treat patients who mobilize hematopoietic stem cells poorly","volume":"118","author":"To","year":"2011","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.681042_bib0055","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbmt.2008.07.004","article-title":"Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation","volume":"14","author":"Pusic","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0060","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbmt.2009.11.012","article-title":"Poor mobilization of hematopoietic stem cells. Definitions, incidence, risk factors and impact on outcome of autologous transplantation","volume":"16","author":"Wuchter","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0025-7753(03)73968-2","article-title":"Causas por las que no se realiza el trasplante de progenitores hematopoy\u00e9ticos en pacientes remitidos a una unidad de trasplante","volume":"121","author":"Sancho","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.3109\/14653249.2012.681042_bib0070","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V83.12.3787.3787","article-title":"Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma","volume":"83","author":"Haas","year":"1994","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.681042_bib0075","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"3102 Investigators. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.681042_bib0080","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","volume":"27","author":"DiPersio","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.3109\/14653249.2012.681042_bib0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1600-0609.2011.01605.x","article-title":"Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells","volume":"86","author":"Basak","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.3109\/14653249.2012.681042_bib0090","article-title":"European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization","author":"H\u00fcbel","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0095","article-title":"Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration","author":"Horwitz","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/bmt.2011.133","article-title":"A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with use of plerixafor","volume":"47","author":"Abhyankar","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0105","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1537-2995.2011.03349.x","article-title":"Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept","volume":"52","author":"Jantunen","year":"2012","journal-title":"Transfusion"},{"key":"10.3109\/14653249.2012.681042_bib0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+cell determination by flow cytometry","volume":"5","author":"Sutherland","year":"1996","journal-title":"Hematotherapy J"},{"key":"10.3109\/14653249.2012.681042_bib0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1537-2995.1998.38498257378.x","article-title":"Minimal number of circulating CD34+cells to ensure success leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation","volume":"38","author":"Perez-Simon","year":"1998","journal-title":"Transfusion"},{"key":"10.3109\/14653249.2012.681042_bib0120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/sj.bmt.1704466","article-title":"Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma","volume":"33","author":"Kuittinen","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ajh.21400","article-title":"Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma","volume":"84","author":"Hosing","year":"2009","journal-title":"Am J Hematol"},{"key":"10.3109\/14653249.2012.681042_bib0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jca.20278","article-title":"Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+cell yield","volume":"26","author":"Duong","year":"2011","journal-title":"J Clin Apher"},{"key":"10.3109\/14653249.2012.681042_bib0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.0041-1132.2004.03321.x","article-title":"The role of diagnosis in patients failing peripheral blood progenitor cell mobilization","volume":"44","author":"Koenigsmann","year":"2004","journal-title":"Transfusion"},{"key":"10.3109\/14653249.2012.681042_bib0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.thj.6200061","article-title":"Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma","volume":"1","author":"Micallef","year":"2000","journal-title":"Hematol J"},{"key":"10.3109\/14653249.2012.681042_bib0145","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"key":"10.3109\/14653249.2012.681042_bib0150","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI43414","article-title":"Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow","volume":"121","author":"Shiozawa","year":"2011","journal-title":"J Clin Invest"},{"key":"10.3109\/14653249.2012.681042_bib0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2003-05-1449","article-title":"Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia","volume":"103","author":"Tournilhac","year":"2004","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.681042_bib0160","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/leu.2008.167","article-title":"Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggest impaired bone marrow niche and HP mobilization","volume":"22","author":"Berger","year":"2008","journal-title":"Leukemia"},{"key":"10.3109\/14653249.2012.681042_bib0165","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/bmt.2011.109","article-title":"Fludarabine as a risk factor for poor stem cell harvest, treatment-realted MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation","volume":"47","author":"Waterman","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0170","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1701461","article-title":"Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system","volume":"22","author":"Clark","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"10.3109\/14653249.2012.681042_bib0175","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.bmt.1701671","article-title":"Management strategies for the hard-to-mobilize patient","volume":"23","author":"Stiff","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.681042_bib0180","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ajh.22038","article-title":"Central and Eastern European Leukemia Group (CELG). Identification of prognostic factors for plerixaforbased hematopoietic stem cell mobilization","volume":"86","author":"Basak","year":"2011","journal-title":"Am J Hematol"},{"key":"10.3109\/14653249.2012.681042_bib0185","article-title":"Comparison of two initial mobilizing strategies of peripheral blood stem cells for autologous transplantation in patients with lymphoma and human immunodeficiency virus infection","author":"Sag\u00fc\u00e9s","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.3109\/14653249.2012.681042_bib0190","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1046\/j.1365-2141.2000.02083.x","article-title":"A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+peripheral blood progenitor cells in normal donors","volume":"109","author":"Anderlini","year":"2000","journal-title":"Br J Haematol"},{"key":"10.3109\/14653249.2012.681042_bib0195","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1537-2995.2010.02891.x","article-title":"Identification of the CD34 enumeration on the day before stem cell harvest that best predicts poor mobilization","volume":"51","author":"Szwajcer","year":"2011","journal-title":"Transfusion"},{"key":"10.3109\/14653249.2012.681042_bib0200","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bmt.2010.236","article-title":"Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention","volume":"46","author":"Sinha","year":"2011","journal-title":"Bone Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324912706977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324912706977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:17:08Z","timestamp":1761430628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324912706977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1465324912706977"],"URL":"https:\/\/doi.org\/10.3109\/14653249.2012.681042","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization.","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3109\/14653249.2012.681042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}